GGrantIndex
Sort

11,323 grants matching glioblastoma

Dynamics of Uracil Accumulation in Human Cellular DNA

$247,987
Oregon State University · R01 · FY2002 · GM

NK Innate Immunity and Oncolytic Virus Therapy

$247,976
Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA

Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe

$247,971
Samy Meroueh · Indiana University Indianapolis · R01 · FY2012 · CA

Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A Targe

$247,971
Samy Meroueh · Indiana University Indianapolis · R01 · FY2011 · CA

GSH TRANSFERASE PI POLYMORPHISM AND DRUG RESISTANCE

$247,820
University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA

Signaling of Integrin Alpha 7

$247,801
Jianhua Luo · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

Project 2: Analysis of non-cell autonomous heterotypic and homotypic cell-cell interaction in invasive cancer models

$247,705
Gunter P. Wagner · Yale University · U54 · FY2020 · CA

Core C - The Molecular Systems Pathology Core

$247,699
Carlos Cordon-Cardo · Columbia Univ New York Morningside · P01 · FY2020 · CA

Core C - The Molecular Systems Pathology Core

$247,698
Carlos Cordon-Cardo · Columbia Univ New York Morningside · P01 · FY2021 · CA

Novel Image-guided, remote-controlled opening of the blood-brain barrier for systemic brain tumor therapy

$247,675
Akiva Mintz · Wake Forest University Health Sciences · P01 · FY2020 · CA

Project 2: Sparing in Tumor Free Animals

$247,662
Charles Limoli · University Of California-Irvine · P01 · FY2021 · CA

glioma Through Genomics and Transgenic Mouse Model

$247,640
University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA

glioma Through Genomics and Transgenic Mouse Model

$247,640
University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA

ARF6 function in cancers driven by RAS hyperactivation

$247,551
Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2023 · CA

ARF6 function in cancers driven by RAS hyperactivation

$247,551
Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2022 · CA

Core 3: Mouse GBM models and Imaging Core

$247,517
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA

Core 3: Mouse GBM models and Imaging Core

$247,517
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA

Core 3: Mouse GBM models and Imaging Core

$247,440
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA

Optimizing Measles Virotherapy in the Treatment of Gliomas

$247,437
Evanthia Galanis · Mayo Clinic Rochester · P50 · FY2012 · CA

Cytochlor/cytofluor: New Tumor Targeted Radiosensitizer

$247,428
Halogenetics · R42 · FY2004 · CA

URACIL-DNA REPAIR IN VITRO AND IN VIVO

$247,366
Oregon State University · R01 · FY2001 · GM

Modulation of Microglia and T Cell Interactions in Malignant Glioma

$247,317
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA

ENHANCING GLIOMA IMMUNOTHERAPY WITH TEMODAR-INDUCED LYMPHOPENIA AND A MULTIVALENT

$247,202
John H Sampson · Duke University · P50 · FY2010 · NS

Modulating Glioblastoma Stem Cell Clonal Evolution Towards Therapeutic Responsiveness

$247,050
Arnold Etame · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2020 · NS

ARF6 function in cancers driven by RAS hyperactivation

$246,879
Jae Hyuk Yoo · University Of Nebraska Medical Center · R00 · FY2021 · CA